Get the Stockscreener App
2.55
2.67%
-0.07
Heartsciences Inc stock is traded at $2.55, with a volume of 18,244.
It is down -2.67% in the last 24 hours and down -15.56% over the past month.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
See More
Previous Close:
$2.62
Open:
$2.74
24h Volume:
18,244
Relative Volume:
0.35
Market Cap:
$8.01M
Revenue:
-
Net Income/Loss:
$-7.29M
P/E Ratio:
-0.1046
EPS:
-24.3686
Net Cash Flow:
$-6.81M
1W Performance:
-4.49%
1M Performance:
-15.56%
6M Performance:
-29.17%
1Y Performance:
-37.35%
1-Day Range:
$2.55
$2.745
1-Week Range:
$2.52
$3.00
52-Week Range:
$2.01
$6.47
Heartsciences Inc Stock (HSCS) Company Profile
Name
Heartsciences Inc
Sector
Industry
Phone
682-237-7781
Address
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
2.55 | 8.23M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Heartsciences Inc Stock (HSCS) Latest News
HeartSciences Inc. Announces Commercial Release of MyoVista Insights™ Version 1.1 Enhancing ECG System Capabilities - Quiver Quantitative
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with ... - Enidnews.com
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 - The Manila Times
HeartSciences (Nasdaq: HSCS) rolls out MyoVista Insights 1.1 to enhance ECG workflows - Stock Titan
HeartSciences (HSCS) to Release Quarterly Earnings on Monday - Defense World
Reviewing Hims & Hers Health (NYSE:HIMS) and HeartSciences (NASDAQ:HSCS) - Defense World
S&P 500, NASDAQ and Dow continue upward trend as Wall Street rises to the edge of its all-time high; Treas - The Economic Times
Risk Off: Why MLPR stock is seen as undervaluedPrice Action & Expert-Curated Trade Recommendations - BỘ NỘI VỤ
How HeartSciences Inc. Equity Warrant stock performs in rate cut cyclesJuly 2025 Levels & Weekly Return Optimization Alerts - Newser
HeartSciences (HSCSW) Stock Analysis Report | Financials & Insights - Benzinga
Will HeartSciences Inc. Equity Warrant stock keep outperforming rivalsJuly 2025 Momentum & Reliable Intraday Trade Alerts - Newser
How HeartSciences Inc. stock performs after earningsJuly 2025 Analyst Calls & Low Risk High Reward Ideas - Newser
HeartSciences (HSCS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
CapEx per share of HeartSciences Inc. Warrant 2022- on Heart Test Lab Rg – NASDAQ:HSCSW - TradingView
Will HeartSciences Inc. Equity Warrant stock deliver shareholder value2025 Price Momentum & Technical Pattern Recognition Alerts - moha.gov.vn
HeartSciences (NASDAQ:HSCS) and Tempus AI (NASDAQ:TEM) Financial Survey - Defense World
HeartSciences (HSCS) Stock Price, Quote, News & History - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Why HeartSciences Inc. stock is a must watch in 2025Quarterly Market Review & Daily Price Action Insights - newser.com
Why HeartSciences Inc. stock is favored by pension fundsTrade Risk Assessment & Long-Term Safe Return Strategies - newser.com
How HeartSciences Inc. stock performs in high volatility marketsJuly 2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
Can trapped investors hope for a rebound in HeartSciences Inc.2025 Winners & Losers & Low Risk Entry Point Guides - newser.com
Will HeartSciences Inc. Equity Warrant stock outperform value stocksMarket Weekly Review & Weekly High Return Forecasts - newser.com
How moving averages guide HeartSciences Inc. Equity Warrant tradingOil Prices & Precise Buy Zone Identification - newser.com
Statistical indicators supporting HeartSciences Inc.’s strengthQuarterly Portfolio Report & Long-Term Investment Growth Plans - newser.com
Sentiment analysis tools applied to HeartSciences Inc.Analyst Downgrade & Risk Managed Trade Strategies - newser.com
Technical analysis overview for HeartSciences Inc. stockJuly 2025 Decliners & Verified Short-Term Plans - newser.com
News impact scoring models applied to HeartSciences Inc.Trade Ideas & Verified Stock Trade Ideas - newser.com
Will HeartSciences Inc. stock keep outperforming rivalsWeekly Trade Report & AI Forecasted Entry and Exit Points - newser.com
What momentum shifts mean for HeartSciences Inc.Trade Entry Summary & Weekly Setup with ROI Potential - newser.com
HeartSciences Inc Stock Analysis and ForecastVolatility Index Analysis & Access High Yield Alerts - earlytimes.in
Order flow analysis tools used on HeartSciences Inc. Equity Warrant2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Heartsciences Inc Stock (HSCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):